- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 11 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-BMA.2: 4 residues within 4Å:- Chain A: N.370, P.618, Q.619, T.620
 
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:Q.619, A:T.620
 
NAG-NAG-BMA.3: 6 residues within 4Å:- Chain A: N.756, T.758, L.961, N.964, Q.965, Q.1110
 
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.964
 
NAG-NAG-BMA.4: 4 residues within 4Å:- Chain A: N.840, S.842, Q.843, Q.974
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 4 residues within 4Å:- Chain A: N.1137, T.1139, H.1140, F.1142
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.7: 3 residues within 4Å:- Chain A: I.1171, V.1172, N.1173
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 5 residues within 4Å:- Chain A: N.748, I.1169, G.1170
 - Chain B: I.833, D.835
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.16: 1 residues within 4Å:- Chain B: N.1173
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 8 residues within 4Å:- Chain B: F.377, G.378, F.381, N.382, V.406, L.407, N.409, S.410
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 3 residues within 4Å:- Chain C: N.370, Q.619, T.620
 
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.620, C:T.620
 
NAG-NAG-BMA.20: 2 residues within 4Å:- Chain C: N.655, T.657
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 4 residues within 4Å:- Chain C: C.1121, I.1171, V.1172, N.1173
 
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-FUC.5: 6 residues within 4Å:- Chain A: S.743, V.744, A.745, E.1111, N.1113
 - Chain B: Q.934
 
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.745
 - Hydrogen bonds: A:S.743, A:N.1113
 
NAG-NAG-FUC.25: 4 residues within 4Å:- Chain A: Q.934
 - Chain C: A.745, E.1111, N.1113
 
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.1113
 
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-BMA-MAN.15: 4 residues within 4Å:- Chain B: N.1137, T.1139, H.1140, F.1142
 
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.23: 7 residues within 4Å:- Chain C: N.756, F.757, T.758, L.961, N.964, Q.965, Q.1110
 
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:N.964
 
NAG-NAG-BMA-MAN.24: 2 residues within 4Å:- Chain C: N.840, S.842
 
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.30: 8 residues within 4Å:- Chain A: N.161, T.163, N.164, V.166, K.168, F.196, Y.199, V.210
 
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: G.271, I.272, N.273
 
Ligand excluded by PLIPNAG.32: 10 residues within 4Å:- Chain A: H.108, V.182, Y.183, Y.184, H.185, N.188, S.190, W.191, L.283, A.301
 
Ligand excluded by PLIPNAG.33: 7 residues within 4Å:- Chain A: T.153, Q.154, E.171, N.204, T.206
 - Chain C: R.394, R.505
 
Ligand excluded by PLIPNAG.34: 7 residues within 4Å:- Chain A: F.381, N.382, S.410, A.411, S.412, W.475, L.480
 
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: G.640, N.642
 
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: N.696, N.697
 
Ligand excluded by PLIPNAG.37: 13 residues within 4Å:- Chain A: N.69, S.70, F.71, T.72, R.73, L.95, P.96, F.97, F.98, S.99, N.100, V.101, Y.130
 
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: Y.67, N.100
 
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain B: Y.183, K.186, N.187, N.188, M.192, S.194
 
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: R.396
 - Chain B: N.204
 
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain B: G.238, G.271, N.273
 
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain B: N.696
 
Ligand excluded by PLIPNAG.43: 6 residues within 4Å:- Chain B: F.368, P.369, N.370, P.618, Q.619, T.620
 
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: G.640, N.642, T.643
 
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: N.655, T.657, Q.683
 - Chain C: I.873
 
Ligand excluded by PLIPNAG.46: 8 residues within 4Å:- Chain C: N.161, A.162, T.163, V.166, M.192, E.193, F.196, Y.199
 
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: Y.67, N.100
 
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain C: N.203, N.204
 
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: G.640, N.642, T.643
 
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: H.694, N.696
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Singh, S. et al., Structure of SARS CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 2RBD-up conformation. To Be Published
 - Release Date
 - 2025-04-16
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 11 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
 - 1 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Singh, S. et al., Structure of SARS CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 2RBD-up conformation. To Be Published
 - Release Date
 - 2025-04-16
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C